Larson Financial Group’s Cullinan Oncology CGEM Stock Holding History

Larson Financial Group’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.45K	Buy	290 +11	+4%	+$211	﹤0.01%	2927
2026 Q2	$5.08K	Sell	279 -75	-21%	-$1.11K	﹤0.01%	2768
2026 Q1	$5.03K	Buy	354 +314	+785%	+$4.04K	﹤0.01%	2608
2025 Q4	$414	Buy	+40	New	+$361	﹤0.01%	3159
2025 Q3	–	Sell	-56	Closed	-$422	–	3476
2025 Q2	$422	Sell	56 -520	-90%	-$4.18K	﹤0.01%	2906
2025 Q1	$4.36K	Buy	+576	New	+$5.53K	﹤0.01%	1920

Other funds holding CGEM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $620M AUM 38.17% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Larson Financial Group's CGEM Position: Q3 2026 in Review

Larson Financial Group increased its Cullinan Oncology (CGEM) stake by 3.9% in Q3 2026, buying an estimated $211 and bringing the position to 290 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2927.

Larson Financial Group first reported a position in CGEM in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.08K in Q2 2026. 55 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.

Larson Financial Group held 290 shares of Cullinan Oncology worth $4.45K as of Q3 2026.
Larson Financial Group bought 11 Cullinan Oncology shares in Q3 2026, an estimated $211.
Cullinan Oncology made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2927 holding.
Larson Financial Group first reported a position in Cullinan Oncology in Q1 2025 and has held it in 6 quarters since.
Larson Financial Group's Cullinan Oncology position peaked at $5.08K in Q2 2026.
55 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.